|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08.08.26 - 12:36
|
Global pharma giants turn to Chinese biotech to tap innovation, valuation growth (SCMP)
|
|
|
Global pharmaceutical giants are doubling down on investing in China's fast-growing biotech companies given the sector's huge room for valuation growth, according to speakers at the Global Health Summit, which concluded in Hong Kong on Saturday.
“Multinational pharmaceutical companies are shifting their business strategies in China away from asset-heavy operations,” said Xu Chenming, head of the healthcare group at Hong Kong-based Citic Securities.
“They are moving towards investing in companies......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.08.26 - 12:18
|
As US-China pharma rivalry heats up, can Hong Kong′s US$8b fund be the global bridge? (SCMP)
|
|
|
Hong Kong is stepping up its efforts to invest in a cluster of biotech companies, positioning itself as a linchpin in Beijing's push to reach new levels of innovation and challenge the United States for dominance in the global pharmaceutical market.
Hong Kong Investment Corporation (HKIC), which manages about US$8 billion in assets and is wholly owned by the Hong Kong government, has built a biotech and healthcare technology investment portfolio covering both traditional Chinese and Western......
|
|
|
|